Send me a link:

*Text messaging rates may apply.

 Dow Down0.72% Nasdaq Down0.50%

More On SRX.AX



News & Info


Analyst Coverage


  • Major Holders
  • Insider Transactions
  • Insider Roster


Sirtex Medical Limited (SRX.AX)

18.61 Down 0.16(0.85%) Jul 25, 2:10AM EDT
ProfileGet Profile for:
Sirtex Medical Limited
101 Miller Street
Level 33
Sydney, NSW 2060
Australia - Map
Phone: 61 2 9964 8400
Fax: 61 2 9964 8410

Index Membership:N/A
Full Time Employees:178

Business Summary 

Sirtex Medical Limited, a biotechnology and medical device company, is engaged in the research, development, manufacture, and distribution of liver cancer treatments utilizing small particle technology. It offers SIR-Spheres microspheres, a medical device used to deliver targeted internal radiation therapy, which contains radioactive yttrium-90 for the treatment of liver cancer. The company markets its products in the Asia-Pacific, Europe, the Middle East, Africa, and the Americas. Sirtex Medical Limited has a collaboration agreement with Guerbet S.A. to evaluate the unmet clinical need in patients with hepatocellular carcinoma, metastatic colorectal cancer, neuroendocrine tumors, and a range of other secondary liver cancers. The company is headquartered in Sydney, Australia.

Key Statistics

Company Websites 
Home Page
Search Yahoo! for:
More on Sirtex Medical Limited

Key Executives 
Mr. Gilman E. Wong , 63
Chief Exec. Officer, Managing Director and Exec. Director
Mr. Darren Smith M.B.A., B.Bus., FCPA, 49
Chief Financial Officer and Company Sec.
Mr. Robert Hardie ,
Global Head of Operations
Dr. David Cade M.D.,
Chief Medical Officer
Mr. Nigel Lange ,
Chief Exec. Officer of EMEA Region
Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in AUD.